Lisa Pham

Hi, it’s Lisa in London. As the world debates how to curb the spread of superbugs, researchers in the US are experimenting with the idea that electric currents could decrease skin infections. But before we get to that...

(Bloomberg) -- AstraZeneca Plc started the week with a market valuation of about £171 billion ($222 billion). By the close on Thursday it had slumped to little more than £150 billion and the drugmaker had lost its spot as the UK’s biggest company by market value to Shell Plc.Most Read from BloombergKey Ballot Initiatives and Local Races Highlight Views on Abortion, ImmigrationParis Restricts Through Traffic in City CenterFrom Housing to Immigration, Key Ballot Initiatives and Local Races to Foll

(Bloomberg) -- AstraZeneca Plc started the week with a market valuation of about £171 billion ($222 billion). By the close on Thursday it had slumped to little more than £150 billion and the drugmaker had lost its spot as the UK's biggest company by market value to Shell Plc.

This week's selloff in renewable energy stocks following Donald Trump 's election victory has been a boon for short sellers betting against clean energy.

(Bloomberg) — This week's selloff in renewable energy stocks following Donald Trump's election victory has been a boon for short sellers betting against clean energy.

Zealand Pharma A/S briefly reclaimed its position as this year’s best performer in the Stoxx 600 Health Care Index on Friday, after analysts at JPMorgan Chase & Co. predicted the Danish biotech firm’s experimental weight-loss drug petrelintide could generate $10 billion in peak sales.

Die Tage im Jahr 2015, als Bayer noch mit mehr als 120 Milliarden Euro bewertet wurde, liegen in weiter Ferne. In dieser Woche sind die Aktien der Leverkusener bisher um rund 15% eingebrochen und steuern auf ihre schlechteste Woche seit fast einem Jahr zu.

(Bloomberg) -- As Bayer AG shares head for their worst week in almost a year, the days of 2015 when the German company was valued at more than €120 billion ($127 billion) are an even more distant memory.

(Bloomberg) -- As Bayer AG shares head for their worst week in almost a year, the days of 2015 when the German company was valued at more than €120 billion ($127 billion) are an even more distant memory.Most Read from BloombergUnder Trump, Prepare for New US Transportation PrioritiesZimbabwe City of 700,000 at Risk of Running Dry by Year-EndSaudi Neom Gets $3 Billion Loan Guarantee From Italy Export Credit Agency SaceThe Urban-Rural Divide Over Highway Expansion and EmissionsBayer — which focuse

(Bloomberg) -- As Bayer AG shares head for their worst week in almost a year, the days of 2015 when the German company was valued at more than €120 billion ($127 billion) are an even more distant memory.